rs1569077009
|
CSNK1E;TPTEP2-CSNK1E
|
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1534891
|
CSNK1E;TPTEP2-CSNK1E
|
Bipolar Disorder
|
|
0.030 |
GeneticVariation |
BEFREE |
No allelic or genotypic association between SNP rs1534891 and bipolar disorder was observed.
|
30445897 |
2018 |
rs1534891
|
CSNK1E;TPTEP2-CSNK1E
|
Bipolar Disorder
|
|
0.030 |
GeneticVariation |
BEFREE |
However, a 4-locus CSNK1E haplotype encompassing the rs1534891 SNP (Z-score=2.685, permuted p=0.0076) and a 3-locus haplotype in ARNTL (Z-score=3.269, permuted p=0.0011) showed a significant association with BD.
|
26283580 |
2015 |
rs1534891
|
CSNK1E;TPTEP2-CSNK1E
|
Bipolar Disorder
|
|
0.030 |
GeneticVariation |
BEFREE |
A multi-locus interaction between rs6442925 in the 5' upstream of BHLHB2, rs1534891 in CSNK1E, and rs534654 near the 3' end of the CLOCK gene, however, is significantly associated with BP (P = 0.00000172).
|
18228528 |
2008 |
rs2075984
|
CSNK1E;TPTEP2-CSNK1E
|
Bipolar Disorder
|
|
0.020 |
GeneticVariation |
BEFREE |
CSNK1E SNP rs2075984 seemed to play a significant role in the development of bipolar disorder in this Korean sample.
|
30445897 |
2018 |
rs2075984
|
CSNK1E;TPTEP2-CSNK1E
|
Bipolar Disorder
|
|
0.020 |
GeneticVariation |
BEFREE |
None of the SNPs showed a significant association with MDD, but a SNP (rs2075984) in CSNK1E and SNP (rs6502097) in CSNK1D were associated with SCZ (P=0.0091, uncorrected) and BD (P=0.030, uncorrected), respectively.
|
22981886 |
2012 |
rs1534891
|
CSNK1E;TPTEP2-CSNK1E
|
Malignant neoplasm of esophagus
|
|
0.010 |
GeneticVariation |
BEFREE |
We also found an association between the cell cycle regulation pathway and esophagus cancer (P-corrected = 1.48 × 10(-) (2)), explained by three SNPs located within or near CSNK1E gene: rs1534891 (P = 1.27 × 10(-) (4)), rs7289981 (P = 3.37 × 10(-) (3)) and rs13054361 (P = 4.09 × 10(-) (3)).
|
24658182 |
2014 |
rs1534891
|
CSNK1E;TPTEP2-CSNK1E
|
Heroin Dependence
|
|
0.010 |
GeneticVariation |
BEFREE |
The results support our previous report of association of CSNK1E SNP rs1534891 with protection from heroin addiction.
|
25521358 |
2014 |
rs1997644
|
CSNK1E;TPTEP2-CSNK1E
|
Heroin Dependence
|
|
0.010 |
GeneticVariation |
BEFREE |
In this study, to identify markers contributing to the genetic susceptibility of the Csnk1ε gene to heroin dependence, we examined the potential association between heroin dependence and 14 single nucleotide polymorphisms (SNPs; rs1997644, rs135764, rs867198, rs135763, rs135757, rs6001090, rs5750581, rs1534891, rs1005473, rs3890379, rs2075984, rs2075983, rs135749, and rs135745) of the Csnk1ε gene using the MassARRAY system.
|
24338102 |
2014 |
rs2075984
|
CSNK1E;TPTEP2-CSNK1E
|
Major Depressive Disorder
|
|
0.010 |
GeneticVariation |
BEFREE |
None of the SNPs showed a significant association with MDD, but a SNP (rs2075984) in CSNK1E and SNP (rs6502097) in CSNK1D were associated with SCZ (P=0.0091, uncorrected) and BD (P=0.030, uncorrected), respectively.
|
22981886 |
2012 |
rs2075984
|
CSNK1E;TPTEP2-CSNK1E
|
Schizophrenia
|
|
0.010 |
GeneticVariation |
BEFREE |
None of the SNPs showed a significant association with MDD, but a SNP (rs2075984) in CSNK1E and SNP (rs6502097) in CSNK1D were associated with SCZ (P=0.0091, uncorrected) and BD (P=0.030, uncorrected), respectively.
|
22981886 |
2012 |
rs1534891
|
CSNK1E;TPTEP2-CSNK1E
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.
|
19934327 |
2009 |
rs1534891
|
CSNK1E;TPTEP2-CSNK1E
|
Malignant neoplasm of prostate
|
|
0.010 |
GeneticVariation |
BEFREE |
Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.
|
19934327 |
2009 |